New malaria shot could offer months of protection
Prevention
Not yet recruiting
This early-stage study tests a single injection of MMV371, a long-acting medicine, to see if it safely prevents malaria in healthy adults and teens aged 12-50 in Rwanda. About 80 participants will get either the study drug or a placebo, and researchers will monitor them for 24 we…
Phase: PHASE1 • Sponsor: Medicines for Malaria Venture • Aim: Prevention
Last updated May 17, 2026 11:49 UTC